Clinical trials
Withdrawn Non-Muscle Invasive Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical Enterprises Europe B.V. | 2 |
| Bioniche Life Sciences Inc. | 1 |
| Case Comprehensive Cancer Center | 1 |
| Eisai Inc. | 1 |
| Hoffmann-La Roche | 1 |
| ImmunityBio, Inc. | 1 |
| Pfizer | 1 |
| Relmada Therapeutics, Inc. | 1 |
| Tocagen Inc. | 1 |
| UroGen Pharma Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 11 |
| Urinary Bladder Neoplasms | 9 |
| Neoplasms | 3 |
| Urologic Neoplasms | 3 |
| Carcinoma in Situ | 2 |
| Neoplasms by Site | 2 |
| Urinary Bladder Diseases | 2 |
| Urogenital Neoplasms | 2 |
| Urologic Diseases | 2 |
| Carcinoma | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.